News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
290,515 Results
Type
Article (15436)
Company Profile (228)
Press Release (274847)
Multimedia
Podcasts (108)
Webinars (12)
Section
Business (90632)
Career Advice (173)
Deals (13456)
Drug Delivery (47)
Drug Development (50927)
Employer Resources (31)
FDA (5949)
Job Trends (5202)
News (145638)
Policy (10088)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (954)
Accelerated approval (32)
ADA (33)
Adcomms (15)
Allergies (118)
Alliances (21771)
ALS (177)
Alzheimer's disease (1200)
Antibody-drug conjugate (ADC) (443)
Approvals (6281)
Artificial intelligence (398)
ASCO (221)
Autoimmune disease (296)
Automation (16)
Bankruptcy (107)
Best Places to Work (4558)
BIO (53)
BIOSECURE Act (6)
Biosimilars (138)
BioSpace Insights (69)
Biotechnology (177)
Bladder cancer (127)
Brain cancer (59)
Breast cancer (447)
Cancer (4291)
Cardiovascular disease (318)
Career advice (163)
Career pathing (12)
CAR-T (299)
CDC (8)
Celiac Disease (1)
Cell therapy (783)
Cervical cancer (25)
Clinical research (45443)
Collaboration (1562)
Commercialization (3)
Company closure (3)
Compensation (824)
Complete response letters (66)
COVID-19 (1132)
CRISPR (114)
C-suite (859)
Cystic fibrosis (122)
Data (6219)
Denatured (23)
Depression (125)
Dermatology (72)
Diabetes (355)
Diagnostics (1496)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (305)
Drug pricing (54)
Drug shortages (3)
Duchenne muscular dystrophy (304)
Earnings (32937)
Editorial (35)
Employer branding (4)
Employer resources (29)
Events (53946)
Executive appointments (737)
FDA (8345)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (23)
Frontotemporal dementia (32)
Funding (1295)
Gene editing (237)
Generative AI (39)
Gene therapy (639)
GLP-1 (582)
Government (1192)
Grass and pollen (3)
Guidances (179)
Healthcare (6741)
Hematology (118)
HIV (31)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (98)
Immunology and inflammation (257)
Immuno-oncology (87)
Indications (151)
Infectious disease (1294)
Inflammatory bowel disease (188)
Inflation Reduction Act (10)
Influenza (60)
Intellectual property (225)
Interviews (20)
IPO (7390)
IRA (13)
Job creations (874)
Job search strategy (137)
JPM (41)
Kidney cancer (11)
Labor market (35)
Layoffs (262)
Leadership (15)
Legal (1404)
Licensing (4)
Liver cancer (48)
Longevity (25)
Lung cancer (571)
Lymphoma (329)
Machine learning (35)
Management (7)
Manufacturing (581)
Marketing (9)
MASH (169)
Medical affairs (1)
Medical device (2727)
Medtech (2762)
Mergers & acquisitions (6859)
Metabolic disorders (979)
mRNA (177)
Multiple sclerosis (133)
NASH (14)
Neurodegenerative disease (370)
Neuropsychiatric disorders (87)
Neuroscience (2479)
Neurotech (1)
NextGen: Class of 2026 (2039)
Non-profit (885)
Now hiring (42)
Obesity (434)
Opinion (146)
Ovarian cancer (198)
Pain (142)
Pancreatic cancer (255)
Parkinson's disease (322)
Partnered (13)
Patents (429)
Patient recruitment (601)
Peanut (51)
People (27464)
Pharmaceutical (29)
Pharmacy benefit managers (6)
Phase 1 (16107)
Phase 2 (21140)
Phase 3 (13333)
Pipeline (6716)
Policy (108)
Postmarket research (853)
Preclinical (6808)
Press Release (30)
Prostate cancer (213)
Psychedelics (70)
Radiopharmaceuticals (297)
Rare diseases (969)
Real estate (1459)
Recruiting (12)
Regulatory (10877)
Reports (20)
Research institute (991)
Resumes & cover letters (20)
Rett syndrome (40)
RNA editing (30)
RSV (24)
Schizophrenia (154)
Series A (253)
Series B (177)
Service/supplier (1)
Sickle cell disease (98)
Special edition (20)
Spinal muscular atrophy (126)
Sponsored (17)
Startups (2036)
State (1)
Stomach cancer (5)
Supply chain (41)
Tariffs (19)
The Weekly (83)
Vaccines (420)
Venture capital (95)
Weight loss (232)
Women's health (49)
Worklife (2)
Date
Today (3)
Last 7 days (302)
Last 30 days (1091)
Last 365 days (18005)
2026 (10645)
2025 (18093)
2024 (20464)
2023 (22413)
2022 (26810)
2021 (27806)
2020 (23355)
2019 (16222)
2018 (11735)
2017 (13743)
2016 (11844)
2015 (14359)
2014 (10393)
2013 (7488)
2012 (7533)
2011 (7617)
2010 (7433)
Location
Africa (156)
Alabama (78)
Alaska (2)
Arizona (91)
Arkansas (6)
Asia (18864)
Australia (3236)
California (9008)
Canada (2289)
China (1122)
Colorado (321)
Connecticut (336)
Delaware (312)
Europe (40535)
Florida (1185)
Georgia (261)
Hawaii (3)
Idaho (18)
Illinois (558)
India (52)
Indiana (216)
Iowa (8)
Japan (336)
Kansas (87)
Kentucky (11)
Louisiana (17)
Maine (14)
Maryland (927)
Massachusetts (7198)
Michigan (127)
Minnesota (320)
Mississippi (3)
Missouri (38)
Montana (17)
Nebraska (6)
Nevada (48)
New Hampshire (22)
New Jersey (2046)
New Mexico (13)
New York (2247)
North Carolina (1054)
North Dakota (7)
Northern California (4587)
Ohio (224)
Oklahoma (11)
Oregon (24)
Pennsylvania (1653)
Puerto Rico (12)
Rhode Island (26)
South America (216)
South Carolina (13)
Southern California (3641)
Tennessee (59)
Texas (1241)
United States (29836)
Utah (125)
Virginia (183)
Washington D.C. (37)
Washington State (738)
West Virginia (1)
Wisconsin (64)
290,515 Results for "sangamo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bankruptcy
Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy
As Sangamo runs out of cash, Eli Lilly and Astellas have emerged as stalking horse bidders for key assets, including a Fabry gene therapy currently being submitted for potential FDA approval.
June 23, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
June 23, 2026
·
7 min read
Press Releases
Sangamo Therapeutics Announces First Quarter 2026 Earnings Call
May 11, 2026
·
1 min read
Press Releases
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
June 8, 2026
·
6 min read
Press Releases
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
April 29, 2026
·
4 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 14, 2026
·
14 min read
Press Releases
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
March 20, 2026
·
1 min read
Press Releases
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
February 4, 2026
·
4 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
March 30, 2026
·
17 min read
Press Releases
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
April 30, 2026
·
4 min read
1 of 29,052
Next
